Fund Holdings — Decheng Capital LLC

Total Portfolio Value:
$466.23M
Total Bought:
$125.35M
Total Sold:
$33.22M
Net Transaction:
+$92.13M
Securities
▲▼
SharesValue
Q3 2024
▲▼
Q4 2024
▲▼
Change
▲▼
Q3 2024
▲▼
Q4 2024
▲▼
Weight (%)
▲▼
Change
▲▼
CG Oncology, Inc.(CGON)5,478,8106,371,669+892,859$206.72M$182.74M39.20%-$23.98M
Nuvation Bio Inc.(NUVB)25,954,43925,954,4390$59.44M$69.04M14.81%+$9.60M
Upstream Bio, Inc.(UPB)03,285,293+3,285,293$0$54.01M11.58%+$54.01M
Newamsterdam Pharma Co Nv
ORDINARY SHARES
590,000770,000+180,000$9.79M$19.79M4.24%+$9.99M
Illumina, Inc.(ILMN)94,76794,7670$12.36M$12.66M2.72%+$305.1K
Arcus Biosciences, Inc.(RCUS)869,790808,789-61,001$13.30M$12.04M2.58%-$1.26M
Krystal Biotech, Inc.(KRYS)71,77276,772+5,000$13.06M$12.03M2.58%-$1.04M
Revolution Medicines, Inc.(RVMD)2,000226,000+224,000$90.7K$9.89M2.12%+$9.79M
Moonlake Immunotherapeutics166,600171,600+5,000$8.40M$9.29M1.99%+$892.2K
Crinetics Pharmaceuticals In157,958167,958+10,000$8.07M$8.59M1.84%+$516.0K
BeyondSpring Inc.SHS(BYSI)4,958,1434,882,651-75,492$11.35M$7.96M1.71%-$3.40M
Merus Nv189,098189,0980$9.45M$7.95M1.71%-$1.50M
Lyell Immunopharma, Inc.(LYEL)011,909,341+11,909,341$0$7.62M1.63%+$7.62M
Zentalis Pharmaceuticals, Inc.(ZNTL)3,108,0952,338,095-770,000$11.44M$7.08M1.52%-$4.35M
Arcellx Inc
COMMON STOCK
21,17784,377+63,200$1.77M$6.47M1.39%+$4.70M
Phathom Pharmaceuticals, Inc.(PHAT)1,250,000694,254-555,746$22.60M$5.64M1.21%-$16.96M
Aclaris Therapeutics, Inc.(ACRS)02,266,667+2,266,667$0$5.62M1.21%+$5.62M
Legend Biotech CorporationADR(LEGN)108,558153,558+45,000$5.29M$5.00M1.07%-$293.3K
Cytokinetics, Incorporated(CYTK)94,043100,000+5,957$4.97M$4.70M1.01%-$261.5K
BioNTech SE(BNTX)040,000+40,000$0$4.56M0.98%+$4.56M
Aura Biosciences, Inc.(AURA)515,555515,5550$4.59M$4.24M0.91%-$355.7K
Equillium, Inc.(EQ)4,447,3084,447,3080$3.70M$3.33M0.71%-$372.7K
4d Molecular Therapeutics In397,835400,000+2,165$4.30M$2.23M0.48%-$2.07M
Vera Therapeutics, Inc.(VERA)69,76749,767-20,000$3.08M$2.10M0.45%-$979.1K
AtriCure, Inc.(ATRC)26,79726,7970$751.4K$818.9K0.18%+$67.5K
Pyxis Oncology, Inc.(PYXS)326,810326,8100$1.20M$509.8K0.11%-$689.6K
GRAIL, Inc.(GRAL)9,6849,6840$133.3K$172.9K0.04%+$39.6K
Nuvation Bio Inc.WARRANTS(NUVB)646,057646,0570$63.2K$148.6K0.03%+$85.3K
GeneDx Holdings Corp.CL A(WGS)103,6040-103,604$4.40M$0—-$4.40M
Longboard Pharmaceuticals In56,3500-56,350$1.88M$0—-$1.88M
Page 1 of 1
Decheng Capital LLC — 13F Holdings — Q4 2024 | TickerTrail